You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 1, July 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (61)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Double-Stranded RNAs (Poly I:C) in the Prevention of Viral Infections

Maurice R. Hilleman, PhD, DSc

Arch Intern Med. 1970;126(1):109-124.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The effective control of viral diseases is a difficult problem and necessitates the exercise of opportunism to explore and utilize all possible approaches. Certain of the viruses for which there is a single or few serotypes lend themselves well to control by vaccines as, eg, poliomyelitis, measles, mumps, rubella, yellow fever, influenza, and smallpox. Other viruses, such as the rhinoviruses which cause the common cold, and the enteroviruses which cause systemic, respiratory, and enteric diseases, are of such diverse antigenic composition as to be unlikely of control by vaccines within the foreseeable future. The interferon mechanism has excited great interest with respect to control of these viruses, especially since the process has the outstanding characteristic of broad-spectrum of activity against essentially all viruses. The promise of the chemical approach (ie, chemoprophylaxis and chemotherapy) is still to be tested, but this avenue is likely to be pursued with increasing vigor as . . . [Full Text PDF of this Article]


Author Affiliations

West Point, Pa

From the Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa.


Footnotes

Received for publication Dec 17, 1969; accepted Jan 7, 1970.

Reprint requests to Division of Virus and Cell Biology Research, Merck Institute for Therapeutic Research, West Point, Pa 19486 (Dr. Hilleman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.